Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report
Van-Khue Ton,Song Li,Kevin John,Borui Li,Elric Zweck,Manreet K Kanwar,Shashank S Sinha,Jaime Hernandez-Montfort,A Reshad Garan,Rachel Goodman,Anthony Faugno,Maryjane Farr,Shelley Hall,Rachna Kataria,Maya Guglin,Esther Vorovich,Mohit Pahuja,Saraschandra Vallabhajosyula,Sandeep Nathan,Jacob Abraham,Neil M Harwani,Gavin W Hickey,Andrew D Schwartzman,Wissam Khalife,Claudius Mahr,Ju H Kim,Arvind Bhimaraj,Paavni Sangal,Qiuyue Kong,Karol D Walec,Peter Zazzali,Justin Fried,Daniel Burkhoff,Navin K Kapur
DOI: https://doi.org/10.1016/j.jacc.2024.04.069
2024-08-01
Abstract:Background: The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) staging was developed to risk stratify cardiogenic shock (CS) severity. Data showing progressive changes in SCAI stages and outcomes are limited. Objectives: We investigated serial changes in CSWG-SCAI stages and outcomes of patients presenting with cardiogenic shock complicating acute myocardial infarction (MI-CS) and heart failure-related CS (HF-CS). Methods: The multicenter CSWG registry was queried. CSWG-SCAI stages were computed at CS diagnosis and 24, 48, and 72 hours. Results: A total of 3,268 patients (57% HF-CS; 27% MI-CS) were included. At CS diagnosis, CSWG-SCAI stage breakdown was 593 (18.1%) stage B, 528 (16.2%) stage C, 1,659 (50.8%) stage D, and 488 (14.9%) noncardiac arrest stage E. At 24 hours, >50% of stages B and C patients worsened, but 86% of stage D patients stayed at stage D. Among stage E patients, 54% improved to stage D and 36% stayed at stage E by 24 hours. Minimal SCAI stage changes occurred beyond 24 hours. SCAI stage trajectories were similar between MI-CS and HF-CS groups. Within 24 hours, unadjusted mortality rates of patients with any SCAI stage worsening or improving were 44.6% and 34.2%, respectively. Patients who presented in or progressed to stage E by 24 hours had the worst prognosis. Survivors had lower lactate than nonsurvivors. Conclusions: Most patients with CS changed SCAI stages within 24 hours from CS diagnosis. Stage B patients were at high risk of worsening shock severity by 24 hours, associated with excess mortality. Early CS recognition and serial assessment may improve risk stratification.
What problem does this paper attempt to address?